Disseminating information about new therapies for Parkinson's disease: misunderstanding or misconduct?
Colosimo
C
C
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D020452:Journalism / Q000592:standards*; D009524:Newspapers as Topic; D010300:Parkinson Disease / Q000188:drug therapy*; D010506:Periodicals as Topic; D011641:Public Relations; D012106:Research / Q000592:standards
D000978:Antiparkinson Agents